AI-28 RECURRENT GLIOBLASTOMAS AFTER TREATMENT WITH BEVACIZUMAB

Bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor, has been evaluated in the treatment of patients with primary or recurrent glioblastoma. We aimed to characterize neuropathological and molecular features in recurrent malignant gliomas after failure of Bevacizumab tr...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Tabatabai, Ghazaleh, Felsberg, Jörg, Sabel, Michael, Kaulich, Kerstin, Hofer, Silvia, Westphal, Manfred, Weller, Michael, Reifenberger, Guido
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2014
Fag:
Abstracts
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217867/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou238.28
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker